XLA is a primary immunodeficiency disease caused by a severe block of B cell development at the pre-B to immature B cell stage that is induced by mutations of the human Bruton’s tyrosine kinase (BTK) gene [2]. The gene discussed is BTK; the disease is Bruton-type agammaglobulinemia.